Daniel Van Plew

Overview

Daniel Van Plew received an average of $7M in total compensation, including $648K in salary, at Regeneron Pharmaceuticals from 2009 to 2021.

Related executives

We found ten more executives who work or worked at Regeneron Pharmaceuticals.

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

Andrew Murphy

Regeneron Pharmaceuticals

Executive Vice President, Research

Joseph LaRosa

Regeneron Pharmaceuticals

General Counsel

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

Marion McCourt

Regeneron Pharmaceuticals

Senior Vice President, Commercial

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

News

You may also like